Staging of Untreated Nasopharyngeal Carcinoma with PET/CT: Comparison with Conventional Imaging Work-up
Overview
Nuclear Medicine
Radiology
Authors
Affiliations
Purpose: We prospectively compared PET/CT and conventional imaging for initial staging of nasopharyngeal carcinoma (NPC).
Methods: A total of 111 patients with histologically proven NPC were investigated with PET/CT and conventional imaging (head-and-neck MRI, chest X-ray, abdominal ultrasound, and bone scan) before treatment. The respective findings were reviewed independently and then compared with each other.
Results: With regard to T staging, PET/CT showed a discrepancy with head-and-neck MRI in 36 (32.4%) of the study subjects. With regard to N staging, PET/CT showed a discrepancy with head-and-neck MRI in 15 (13.5%) patients. Among the discordant cases, MRI was superior in demonstrating tumor involvement in the parapharyngeal space, skull base, intracranial area, sphenoid sinus, and retropharyngeal nodes while PET/CT was superior in demonstrating neck nodal metastasis. PET/CT disclosed 13 of 16 patients with distant malignancy compared with four patients disclosed by conventional imaging work-up. The false-positive rate of PET/CT was 18.8%. PET/CT correctly modified M staging in eight patients (7.2%) and disclosed a second primary lung malignancy in one patient (0.9%).
Conclusion: In NPC patients, MRI appears to be superior to PET/CT for the assessment of locoregional invasion and retropharyngeal nodal metastasis. PET/CT is more accurate than MRI for determining cervical nodal metastasis and should be the better reference for the neck status. PET/CT has an acceptable diagnostic yield and a low false-positive rate for the detection of distant malignancy and can replace conventional work-up to this aim. PET/CT and head-and-neck MRI are suggested for the initial staging of NPC patients.
Wu B, Chen X, Cao C Curr Oncol Rep. 2025; .
PMID: 39998781 DOI: 10.1007/s11912-025-01651-9.
Niu X, Xue F, Ou D, Zheng Y, Hu C, Shen C Int J Med Sci. 2025; 22(4):933-939.
PMID: 39991768 PMC: 11843132. DOI: 10.7150/ijms.105995.
Schneider D, Ok A, Simpfendorfer C, Forney M, Subhas N Skeletal Radiol. 2024; .
PMID: 39080030 DOI: 10.1007/s00256-024-04761-w.
Comparison of [F]FDG and [ Ga]pentixafor PET/CT in Nasopharyngeal Carcinoma.
Liu M, Chen X, Ding H, Shu Q, Zheng Y, Chen Y Mol Imaging Biol. 2024; 26(4):658-667.
PMID: 38627276 DOI: 10.1007/s11307-024-01913-1.
Kong F, Pan G, Ni M, Du C, Hu C, Ying H Ther Adv Med Oncol. 2024; 16:17588359241233235.
PMID: 38379851 PMC: 10878206. DOI: 10.1177/17588359241233235.